Pitcairn Co. decreased its stake in Monsanto Co. (NYSE:MON) by 47.2% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 14,150 shares of the company’s stock after selling 12,666 shares during the period. Pitcairn Co.’s holdings in Monsanto were worth $1,463,000 as of its most recent SEC filing.
Other large investors also recently modified their holdings of the company. Hyman Charles D bought a new stake in shares of Monsanto during the first quarter valued at $623,000. Cortland Associates Inc. MO boosted its stake in shares of Monsanto by 2.1% in the first quarter. Cortland Associates Inc. MO now owns 151,363 shares of the company’s stock valued at $13,281,000 after buying an additional 3,159 shares during the last quarter. IFP Advisors Inc boosted its stake in shares of Monsanto by 38.0% in the first quarter. IFP Advisors Inc now owns 7,121 shares of the company’s stock valued at $625,000 after buying an additional 1,962 shares during the last quarter. Virginia Retirement System bought a new stake in shares of Monsanto during the first quarter valued at $626,000. Finally, Mn Services Vermogensbeheer B.V. bought a new stake in shares of Monsanto during the first quarter valued at $846,000. 79.06% of the stock is currently owned by institutional investors.
Shares of Monsanto Co. (NYSE:MON) traded up 1.44% during midday trading on Wednesday, reaching $104.36. The company’s stock had a trading volume of 5,719,552 shares. The stock has a market capitalization of $45.67 billion, a price-to-earnings ratio of 45.93 and a beta of 1.24. The company has a 50 day moving average of $105.82 and a 200-day moving average of $100.43. Monsanto Co. has a 52 week low of $81.22 and a 52 week high of $114.26.
Monsanto (NYSE:MON) last announced its earnings results on Wednesday, June 29th. The company reported $2.17 EPS for the quarter, missing analysts’ consensus estimates of $2.40 by $0.23. Monsanto had a net margin of 7.76% and a return on equity of 37.98%. The business earned $4.19 billion during the quarter, compared to analysts’ expectations of $4.49 billion. During the same period in the previous year, the company posted $2.39 earnings per share. Monsanto’s quarterly revenue was down 8.5% on a year-over-year basis. Equities research analysts predict that Monsanto Co. will post $4.46 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, October 7th will be issued a $0.54 dividend. The ex-dividend date of this dividend is Wednesday, October 5th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 2.07%. Monsanto’s payout ratio is 89.26%.
Several equities research analysts have weighed in on the company. Deutsche Bank AG reissued a “buy” rating and set a $100.00 price objective on shares of Monsanto in a research note on Wednesday, June 1st. TheStreet raised Monsanto to a “buy” rating in a research note on Thursday, May 26th. JPMorgan Chase & Co. reaffirmed a “neutral” rating on shares of Monsanto in a research note on Wednesday, May 25th. Atlantic Securities cut Monsanto from an “overweight” rating to a “neutral” rating and cut their target price for the company from $109.62 to $105.00 in a research note on Friday, May 27th. Finally, Vetr raised Monsanto from a “buy” rating to a “strong-buy” rating and set a $123.50 target price on the stock in a research note on Thursday, May 26th. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $113.02.
In other news, CEO Michael K. Stern sold 12,797 shares of the company’s stock in a transaction dated Wednesday, July 13th. The shares were sold at an average price of $101.77, for a total value of $1,302,350.69. Following the completion of the sale, the chief executive officer now directly owns 21,583 shares of the company’s stock, valued at $2,196,501.91. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, COO Brett D. Begemann sold 27,980 shares of the company’s stock in a transaction dated Thursday, July 14th. The shares were sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the completion of the sale, the chief operating officer now directly owns 102,480 shares of the company’s stock, valued at $10,618,977.60. The disclosure for this sale can be found here. 0.88% of the stock is currently owned by insiders.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Co. (NYSE:MON).
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.